Login / Signup

A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer.

Christine AuberleFeng GaoMark SloanDaniel MorgenszternLinda WinklerJeffrey P WardSiddhartha DevarakondaTimothy P ReardenRamaswamy GovindanSaiama N Waqar
Published in: Journal of thoracic disease (2024)
In this pilot study in heavily pretreated and molecularly selected patients with metastatic NSCLC, nintedanib showed modest activity.
Keyphrases
  • advanced non small cell lung cancer
  • idiopathic pulmonary fibrosis
  • epidermal growth factor receptor
  • interstitial lung disease
  • systemic sclerosis
  • small cell lung cancer
  • rheumatoid arthritis